Outcomes of hearing aid fitting for older people with hearing impairment and their significant others

As hearing impairment affects communication. it seems intuitive that both the person with hearing impairment and the significant other (SO) will experience effects as a result of the impairment and subsequent rehabilitation. The present study examined the effect that hearing impairment and aural rehabilitation has on the person with hearing impairment and the SO's quality of life (QOL). Ninety-three people with hearing impairment completed a measure of hearing-specific QOL (Hearing Handicap Inventory for the Elderly) and health-related QOL (Short Form-36), while 78 SOs completed a modified version of the Quantified Denver Scale and the Short Form-36. prior to and 3 months following hearing aid fitting. The results emphasize the significant impact of hearing impairment on both the person with hearing impairment and the SO. The results also demonstrate the effective role that hearing aids play in reducing Such negative effects for both parties.

Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis

Aims To investigate the concentration-effect relationship and pharmacokinetics of leflunomide in patients with rheumatoid arthritis (RA). Methods Data were collected from 23 RA patients on leflunomide therapy (as sole disease modifying antirheumatic drug (DMARD)) for at least 3 months. Main measures were A77 1726 (active metabolite of leflunomide) plasma concentrations and disease activity measures including pain, duration/intensity of morning stiffness, and SF-36 survey. A population estimate was sought for apparent clearance (CL/F ) and volume of distribution was fixed (0.155 l kg(-1)). Factors screened for influence on CL/F were weight, age, gender and estimated creatinine clearance. Results Significantly higher A77 1726 concentrations were seen in patients with less swollen joints and with higher SF-36 mental summary scores than in those with measures indicating more active disease (P < 0.05); concentration-effect trends were seen with five other disease activity measures. Statistical analysis of all disease activity measures showed that mean A77 1726 concentrations in groups with greater control of disease activity were significantly higher than those in whom the measures indicated less desirable control (P < 0.05). There was large between subject variability in the dose-concentration relationship. A steady-state infusion model best described the pharmacokinetic data. Inclusion of age as a covariate decreased interindividual variability (P < 0.01), but this would not be clinically important in terms of dosage changes. Final parameter estimate (% CV interindividual variability) for CL/F was 0.0184 l h(-1) (50%) (95% CI 0.0146, 0.0222). Residual (unexplained) variability (% CV) was 8.5%. Conclusions This study of leflunomide in patients using the drug clinically indicated a concentration-effect relationship. From our data, a plasma A77 1726 concentration of 50 mg l(-1) is more likely to indicate someone with less active disease than is a concentration around 30 mg l(-1). The marked variability in pharmacokinetics suggests a place for individualized dosing of leflunomide in RA therapy.

Measurement properties of the CHAMPS physical activity questionnaire in a sample of older Australians

Background: The effective evaluation of physical activity interventions for older adults requires measurement instruments with acceptable psychometric properties that are sufficiently sensitive to detect changes in this population. Aim: To assess the measurement properties (reliability and validity) of the Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire in a sample of older Australians. Methods: CHAMPS data were collected from 167 older adults (mean age 79.1 S.D. 6.3 years) and validated with tests of physical ability and the SF-12 measures of physical and mental health. Responses from a sub-sample of 43 older adults were used to assess 1-week test-retest reliability. Results: Approximately 25% of participants needed assistance to complete the CHAMPS questionnaire. There were low but significant correlations between the CHAMPS scores and the physical performance measures (rho=0.14-0.32) and the physical health scale of the SF-12 (rho=0.12-0.24). Reliability coefficients were highest for moderate-intensity (ICC=0.81-0.88) and lowest for vigorous-intensity physical activity (ICC=0.34-0.45). Agreement between test-retest estimates of sufficient physical activity for health benefits (>= 150 min and >= 5 sessions per week) was high (percent agreement = 88% and Cohen's kappa = 0.68). Conclusion: These findings suggest that the CHAMPS questionnaire has acceptable measurement properties, and is therefore suitable for use among older Australian adults, as long as adequate assistance is provided during administration. (c) 2006 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.

Motherhood plans among young Australian women - Who Wants children these days?

Fertility rates in the developed world have been below replacement level for 25 years, and it is often assumed that this results from deliberate, unconstrained individual choice. Data from 7448 childless women aged 22 to 27, participating in the Australian Longitudinal Study on Women's Health, indicate that 9 per cent aspire to childlessness, with 72 per cent wanting I or 2 children and 19 per cent more. Differences in psychological functioning disappear after adjustment for socioeconomic variables. Women wanting 1 or 2 children also want paid work, while those wanting many children generally have traditional aspirations. Policy-makers need to consider strategies that support women to negotiate motherhood and paid work.

Exploring attitudes towards dietary modification and nutritional supplementation in people with and without age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause for visual impairment and blindness registration in the developed world. Due to the large amounts of conflicting AMD research on the role of nutrition and antioxidant intake, it is difficult for patients and practitioners to determine which measures can be taken to slow down the disease progression. The aim of this research was to determine the beliefs and knowledge that patients with AMD have about nutrition, to identify whether their condition is preventing them from eating a healthy diet, and to discover what their diet consists of. For the initial study, 158 participants with AMD (mean age 79 ± 7.8 years) and 50 participants without AMD (mean age 67 ± 8 years) were recruited from the Macular Society helpline, or from optometric practice. Participants had a 25 minute telephone interview where a 36-question survey was completed. The survey elicited demographic information, and questions covered the knowledge that participants had on nutrition and their current diet. The results from this survey uncovered three major findings: 1) 100% of AMD participants felt that they do not have enough information and support from eye-care practitioners regarding nutrition, 2) AMD patients are confused over, and display a lack of knowledge of, which foods are beneficial for eye health and when and what nutritional supplements to take, evidenced by 65% of participants not taking the correct dosage 3) AMD patients are not eating enough nutrients that would be beneficial for their condition - consuming an average of 1.4mg of lutein and zeaxanthin rather than the recommended 10mg. A clinical decision-making aid was created as an intervention based upon these findings. The aim of the aid was to help eye-care practitioners give the correct nutritional advice to their patients. Founded on the AREDS 2 inclusion and exclusion criteria, practitioners are able to identify which patients could benefit from a nutritional supplement, and which patients could benefit from dietary modification. An evaluation of the aid with 72 qualified eye-care practitioners exhibited a statistically significant increase in confidence after using the aid for two weeks. An evaluation using 51 student optometrists showed a statistically significant increase in confidence and a statistically significant increase in appropriate management of patients after using the aid. This project has elicited findings that are significant for AMD patient education. It is hoped that through these studies, patients will receive consistent advice about the risk factors for AMD, the link between AMD and nutrition, and the importance of maintaining a healthy, well-balanced diet.

Randomised trial of levonorgestrel intrauterine system compared to usual medical treatment for heavy menstrual bleeding:the ECLIPSE Trial

Objective: Heavy menstrual bleeding (menorrhagia) is a common problem, yet evidence is limited to inform therapeutic decisions.We compared the levonorgestrel-releasing intrauterine system(LNG-IUS) to usual medical treatment in a pragmatic randomised trial in primary care. Methods: We randomly assigned 571 women consulting their primary care providers with menorrhagia to LNG-IUS or to usual medical treatment as clinically appropriate (tranexamic acid, mefenamic acid, combined estrogen/progestogen or progestogen only). The primary outcome was a patient-reported measure ofimpact of menorrhagia, the validated Menorrhagia Multi-Attribute Scale (MMAS), assessed over 2 years. Secondary measures included generic quality of life (SF-36), sexual activity and surgical intervention.Results MMAS scores improved from baseline in both the LNG-IUS and usual medical treatment groups by 6 months (mean increases 32.7 points versus 21.4 points, respectively; P < 0.001for both) and were maintained over 2 years, but improvements were significantly greater with LNG-IUS (mean between-group difference 13.4 points, 95%CI, 9.9–16.9; P < 0.001).All domains of MMAS (practical difficulties, social life, family life,work/daily routine, psychological well being and physical health)improved significantly more with LNG-IUS, as were seven of the eight domains of SF-36. More women were still using LNG-IUSthan usual medical treatment at 2 years (64% versus 38%,P < 0.001). There were no significant between-group differences in surgical intervention rates or sexual activity scores. There were no serious adverse events in either group.Conclusions Among women presenting to primary care providers with menorrhagia, LNG-IUS was more effective than usual medical treatment at reducing the impact of this problem on their quality of life. In practice therefore, conventional treatments, such as tranexamic and mefenamic acid, remain helpful choices in women for whom LNG-IUS is considered unsuitable, or due to individual preference. For other women, LNG-IUS can be confidently recommended as an effective initial medical therapy for menorrhagia. Funding: This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 02/06/02)

Epilepszia betegségteher felmérés Magyarországon

Tanulmányomban a 2008 októberében kezdődött Epilepszia Betegségteher Felmérés Magyarországon módszertanát és eredményeit szeretném bemutatni és összehasonlítani a nemzetközi adatokkal. Az epilepszia a felnőtteknél a neurológiai betegségek közül a második leggyakoribb megbetegedés (Magyarországon kb.50-60.000 fő). A keresztmetszeti, kérdőíves felmérés az Egészség-gazdaságtani és Egészségügyi Technológiaelemzési Kutatóközpont és három budapesti Epilepszia Centrum együttműködésében zajlott, több mint 100 beteg bevonásával. A kérdőív egy általános epilepszia kérdőívből és két generikus életminőség kérdőívből (EQ-5D és SF-36) állt. Az eredmények alátámasztották, hogy a terápia-rezisztens betegek éves társadalmi költsége az átlagnál jóval magasabb, főleg a rokkant nyugdíj költsége miatt, és jelentős életminőség romlás is megfigyelhető, elsősorban a rohamtól való félelem miatt.

The effects of age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and relationship with the partner on the quality of life of men with prostate cancer

Prostate cancer, the leading cause of cancer in men, has positive survival rates and constitutes a challenge to men with its side effects. Studies have addressed the bivaritate relationships between prostate cancer treatment side effects masculinity, partner relationship, and quality of life (QOL). However, few studies have highlighted the relationships among prostate cancer treatment side effects (i.e., sexual dysfunction, urinary incontinence), masculinity, and relationship with the partner together on QOL in men. Most studies were conducted with predominately Caucasian sample of men. Miami is a unique multiethnic setting that hosts Cuban, Columbian, Venezuelan, Haitian, other Latin American and Caribbean communities that were not represented in previous literature. The purpose of this study was to examine relative contributions of age, ethnicity, sexual dysfunction, urinary incontinence, masculinity, and perception of the relationship with the partner on the quality of life in men diagnosed with prostate cancer. Data were collected using self administered questionnaires measuring demographic variables, sexual and urinary functioning (UCLA PCI), masculinity (CMNI), partner relationship (DAS), and QOL (SF-36). A total of 117 partnered heterosexual men diagnosed with prostate cancer were recruited from four urology clinics in Miami, Florida. Men were 67.47 (SD = 8.42) years old and identified themselves to be of Hispanic origin (54.3 %, n = 63). Findings demonstrated that there was a significant moderate negative relationship between urinary and sexual functioning of men. There was a significant strong negative association between men's perceived relationship with partner and masculinity. There was a weak negative relationship between the partner relationship and QOL. Hierarchal multiple regression showed that the partner relationship (β = -.25, t (91) = -2.28, p = .03) significantly contributed overall to QOL. These findings highlight the importance of the relationship satisfaction in the QOL of men with prostate cancer. Nursing interventions to enhance QOL for these men should consider strengthening the relationship and involving the female partner as an active participant.^

Assessing the health outcomes of the family members of disabled individuals

The health utilization and death rates were captured for the family members of disabled individuals over a fifteen-year period to determine if exposure to disability in the family manifests poor health outcomes. Data from the Newfoundland Adult Health Survey (1995) was linked to fifteen years, 1995- 2010, of provincial health administrative data including hospital data, physician claims, and death records from the provincial health care system. The health records and survey data were analyzed in relation to the disability exposure burden experienced when a family member is disabled. The level of disability exposure burden was quantified based on the addition of individual disability scores for each family member. Disability exposure burden was associated with increased number of hospital separations, total hospitalization days and the number of physician visits, both General Practitioner and Specialist (p<0.1) but there was no association between death (p>0.1) and disability exposure burden. Family members of disabled individuals experienced increased rates of hospital separations, hospitalization days, and physician visits suggesting that deleterious health outcomes may be introduced when individuals are exposed to disability in the family unit.

Graded Exercise Therapy Guided Self-Help Trial for Patients with Chronic Fatigue Syndrome (GETSET): Protocol for a Randomized Controlled Trial and Interview Study

Background: Chronic fatigue syndrome, also known as myalgic encephalomyelitis (CFS/ME), is characterized by chronic disabling fatigue and other symptoms, which are not explained by an alternative diagnosis. Previous trials have suggested that graded exercise therapy (GET) is an effective and safe treatment. GET itself is therapist-intensive with limited availability. Objective: While guided self-help based on cognitive behavior therapy appears helpful to patients, Guided graded Exercise Self-help (GES) is yet to be tested. Methods: This pragmatic randomized controlled trial is set within 2 specialist CFS/ME services in the South of England. Adults attending secondary care clinics with National Institute for Health and Clinical Excellence (NICE)-defined CFS/ME (N=218) will be randomly allocated to specialist medical care (SMC) or SMC plus GES while on a waiting list for therapist-delivered rehabilitation. GES will consist of a structured booklet describing a 6-step graded exercise program, supported by up to 4 face-to-face/telephone/Skype™ consultations with a GES-trained physiotherapist (no more than 90 minutes in total) over 8 weeks. The primary outcomes at 12-weeks after randomization will be physical function (SF-36 physical functioning subscale) and fatigue (Chalder Fatigue Questionnaire). Secondary outcomes will include healthcare costs, adverse outcomes, and self-rated global impression change scores. We will follow up all participants until 1 year after randomization. We will also undertake qualitative interviews of a sample of participants who received GES, looking at perceptions and experiences of those who improved and worsened. Results: The project was funded in 2011 and enrolment was completed in December 2014, with follow-up completed in March 2016. Data analysis is currently underway and the first results are expected to be submitted soon. Conclusions: This study will indicate whether adding GES to SMC will benefit patients who often spend many months waiting for rehabilitative therapy with little or no improvement being made during that time. The study will indicate whether this type of guided self-management is cost-effective and safe. If this trial shows GES to be acceptable, safe, and comparatively effective, the GES booklet could be made available on the Internet as a practitioner and therapist resource for clinics to recommend, with the caveat that patients also be supported with guidance from a trained physiotherapist. The pragmatic approach in this trial means that GES findings will be generalizable to usual National Health Service (NHS) practice.

NI health and social care inequalities monitoring system (HSCIMS) - health inequalities in Northern Ireland: key facts 2015

This key facts publication provides an interim update to the NI health & social care inequalities monitoring system (HSCIMS) regional reports which are published every other year. It presents a summary of the latest position and inequality gaps between the most deprived areas and both the least deprived areas and the NI average in addition to a regional comparison with rural areas for a range of health outcomes included within the HSCIMS series, in addition to the health survey Northern Ireland (HSNI).

Patient-reported outcomes and visual acuity after 12 months of anti-VEGF-treatment for sight-threatening diabetic macular edema in a real world setting

Aims To examine objective visual acuity measured with ETDRS, retinal thickness (OCT), patient reported outcome and describe levels of glycated hemoglobin and its association with the effects on visual acuity in patients treated with anti-VEGF for visual impairment due to diabetic macular edema (DME) during 12 months in a real world setting. Methods In this cross-sectional study, 58 patients (29 females and 29 males; mean age, 68 years) with type 1 and type 2 diabetes diagnosed with DME were included. Medical data and two questionnaires were collected; an eye-specific (NEI VFQ-25) and a generic health-related quality of life questionnaire (SF-36) were used. Results The total patient group had significantly improved visual acuity and reduced retinal thickness at 4 months and remains at 12 months follow up. Thirty patients had significantly improved visual acuity, and 27 patients had no improved visual acuity at 12 months. The patients with improved visual acuity had significantly improved scores for NEI VFQ-25 subscales including general health, general vision, near activities, distance activities, and composite score, but no significant changes in scores were found in the group without improvements in visual acuity. Conclusions Our study revealed that anti-VEGF treatment improved visual acuity and central retinal thickness as well as patient-reported outcome in real world 12 months after treatment start.

O afecto na adaptação dos estudantes do primeiro ano do Ensino Superior e seus correlatos

A entrada e a adaptação ao Ensino Superior consistem num período muito emocional, causador de manifestações positivas, bem como de expressões negativas, como sejam a ansiedade e o stresse. Neste sentido, perspectiva-se que quanto mais os estudantes do ensino superior se sentem integrados e felizes mais irão evitar e minimizar as consequências associadas a afectos negativos, que podem, em grande parte dos casos, estar na origem ou contribuir para o insucesso académico e até mesmo para o abandono escolar. O presente estudo pretende investigar em que medida as variáveis afecto negativo e afecto positivo estão relacionadas com factores sociodemográficos idade, sexo, curso e saída de casa ou não aquando do ingresso no ensino superior, em estudantes do primeiro ano do ensino superior, assim como explorar a relação entre o afecto (positivo e negativo) e a percepção de saúde da amostra em estudo. Para o efeito foi utilizado o Questionário Sócio–Demográfico do Questionário de Vivências Académicas Reduzido (QVA-r) (Almeida, Soares & Ferreira, 2002), a Escala de Afecto Positivo e Negativo (PANAS), adaptado, por Galinha e Ribeiro (2005), e os itens 1 e 2 do Questionário de Estado de Saúde SF–36 (Ribeiro, 2005). Estes instrumentos foram administrados a uma amostra de 102 estudantes do 1º ano de ensino superior na região Norte de Portugal (26,5% do sexo masculino e 72,5% do sexo feminino). Os resultados obtidos permitem concluir que, a amostra em estudo, o sexo e a percepção de saúde dos participantes são factores diferenciadores no que concerne ao afecto (negativo e positivo), sendo que o curso, a saída ou não de casa e a idade não o são. Estes resultados têm implicações ao nível de intervenção no afecto no âmbito da adaptação ao Ensino Superior.

Sonolência Diurna Excessiva e Otimismo em Estudantes do 1º Ano do Ensino Superior

Os principais objetivos do presente estudo são analisar a prevalência da sonolência diurna excessiva (SDE) em estudantes do Ensino Superior (ES), bem como os seus níveis de otimismo. Participaram no presente estudo 162 estudantes universitários de várias faculdades de ES privado, de ambos os sexos, com idades compreendidas entre os 17 e os 46 anos (M=20,49; DP=5,153) e que frequentavam diferentes cursos (Psicologia, Ciências da Comunicação, Análises Clínicas, Ciências Farmacêuticas e Fisioterapia). O protocolo de recolha de dados foi constituído por um questionário sociodemográfico, dois itens do Questionário do Estado de Saúde (SF-36), a Escala de Sonolência de Epworth (ESE) e a Escala de Orientação para a Vida (LOT-R). A ESE apresentou um valor de alfa de Cronbach de α=0,68 e o LOT-R um valor de alfa de Cronbach de α=0,84. Os principais resultados descritivos mostram uma pontuação média na ESE de 8,98 (DP=3,85), que corresponde a uma prevalência de 32,1% (n=52) de SDE. A pontuação média obtida com a LOT-R foi de 14,3 (DP=4,77), que corresponde a 65,4% (n=106) de estudantes otimistas. Foram encontradas correlações estatisticamente significativas entre a idade e a SDE, mas não entre a SDE e as variáveis de perceção de saúde. Os resultados diferenciais não apresentaram significância estatística na SDE, quando o sexo, o curso e a situação de residência foram tidos em consideração. A idade foi assumida, nas análises de regressão linear, como variável preditora explicativa de 3% da variância dos resultados da ESE. Relativamente ao otimismo, este mostrou-se correlacionado com a perceção do estado de saúde no momento, mas não com a SDE, idade e transição de saúde. Não foi encontrada significância estatística no otimismo quando o sexo, o curso e a situação de residência foram considerados. As análises de regressão linear identificaram como modelo preditor explicativo de cerca de 12% da variação total do LOT-R o modelo que integra a idade e a perceção do estado de saúde no momento. Estudos posteriores devem ser realizados para se aferir a prevalência de SDE e caraterizar o otimismo em estudantes universitários, bem como a relação entre ambos e com outras variáveis relevantes, de foma a apoiar, adequadamente a intervenção.

A qualidade de vida dos idosos com coxartrose

Um dos fenómenos marcantes desde os meados do século XX até aos dias de hoje é o processo de envelhecimento das sociedades a nível mundial (Moura, 2006). Envelhecer de forma saudável e com boa qualidade de vida é algo que todas a pessoas desejam, mas muitas vezes o envelhecimento é acompanhado por diferentes tipos de alterações que poderão provocar alterações da qualidade de vida do idoso. A investigação científica acerca da relação entre a qualidade de vida do idoso com coxartrose e o impacto da artroplastia total da anca é ainda um tema recente. Assim esta investigação tem como objetivo avaliar a perceção da qualidade de vida dos idosos com coxartrose, antes da cirurgia da artroplastia total da anca, e avaliar a perceção da qualidade de vida dos idosos após o sexto mês da artroplastia total da anca. Procedeu-se assim a um estudo de natureza descritivo, longitudinal e de abordagem quantitativa, com 35 utentes idosos que foram submetidos a artroplastia total da anca por patologia de coxartrose. Foi utilizado como instrumento de recolha de dados o questionário genérico de qualidade de saúde SF-36 no dia antes da cirurgia e após 6 meses da artroplastia total da anca e um questionário de forma a fazer uma caracterização sócio - demográfica da amostra. Verifica-se que a perceção da qualidade de vida dos idosos com coxartrose, antes da cirurgia da artroplastia total da anca é limitada em várias dimensões como função física desempenho físico, dor corporal, perceção geral de saúde, vitalidade, função social, desempenho emocional, saúde mental e transição de saúde. Após o sexto mês da artroplastia total da anca, a perceção da qualidade de vida dos idosos apresenta-se na maioria dos sujeitos melhorada.